A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting

  • Laura McCullagh
  • , Lesley Tilson
  • , Cathal Walsh
  • , Michael Barry

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'A cost-effectiveness model comparing rivaroxaban and dabigatran etexilate with enoxaparin sodium as thromboprophylaxis after total hip and total knee replacement in the Irish healthcare setting'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science